MedPath
NMPA Approval

Befotertinib Mesylate Capsules

国药准字H20230012

September 28, 2023

Drug Information

甲磺酸贝福替尼胶囊

赛美纳

胶囊剂

50mg(按C₂₉H₃₂F₃N₇O₂计)

化学药品

September 28, 2023

Company Information

Applicant Company

浙江省杭州市临平区经济技术开发区兴中路355号

Manufacturing Company

浙江省杭州市临平区经济技术开发区兴中路355号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲磺酸贝福替尼胶囊 - NMPA 批准文号 | MedPath